Lantheus Holdings Inc (LNTH) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Lantheus Holdings Inc   (NASDAQ: LNTH)
 

Lantheus Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lantheus Holdings Inc inventory turnover ratio, the Lantheus Holdings Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 10.09 in the second quarter 2026, LNTH's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Lantheus Holdings Inc in Jun 30 2026 quarter, has decreased to 36 days, compare to 37 days, in the Mar 31 2026 quarter.

Within Healthcare sector 33 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 411, from total ranking in the first quarter 2026 at 514.

LNTH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lantheus Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LNTH Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -7.41 % -11.26 % -4.93 % -12.42 % -11.85 %
Y / Y Cost of Sales Growth 6.81 % 8.15 % 16.08 % 18.38 % -0.72 %
Inventory Turnover Ratio (TTM) 10.09 9.75 9.29 8.82 8.16
LNTH's Total Ranking # 411 # 514 # 481 # 497 # 503
Average inventory processing period 36 37 39 41 45
Seq. Inventory Growth -6.18 % -5.16 % 4.25 % -0.19 % -10.08 %
Seq. Cost of Sales Growth 0.22 % -12.05 % 3.11 % 17.52 % 1.48 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 34
Overall Market # 411

Inventory Turnover Ratio Statistics
High Average Low
13.59 8.14 5.14
(Mar 31 2023)   (Dec 31 2018)



LNTH Company Profile >> Back to LNTH Efficiency Comparisons >> Compare LNTH Inventory Turnover Ratio to its Competitors

Financial Statements
Lantheus Holdings Inc 's Inventories $ 58 Millions Visit LNTH's Balance sheet
Lantheus Holdings Inc 's Cost of Revenues TTM $ 619 Millions Visit LNTH's Income Statement
What are LNTH's Sales? Visit LNTH's Sales by Segment

Other Inventory Turnover Ratios
Lantheus Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LNTH's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LNTH's Competitors
Inventory Turnover Ratio for LNTH's Suppliers
Inventory Turnover Ratio for LNTH's Customers

You may also want to know
LNTH's Sales Growth Rates LNTH's Pe Price to earnings ratio LNTH's Receivables Turnover Ratio LNTH's Stock Quote
LNTH's Net Income Growth Rates LNTH's Ps Price to Sales ratio LNTH's Sales per Employee LNTH's Asset Turnover Ratio
LNTH's Net Margin LNTH's Pb Price to Book ratio LNTH's Financial Strength Ratios LNTH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Aspira Women s Health inc   22.57 $ 5.988  Millions$ 0  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Prophase Labs Inc   22.13 $ 2.633  Millions$ 0  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Adapthealth Corp   18.95 $ 2,676.899  Millions$ 141  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Edap Tms Sa  12.79 $ 62.351  Millions$ 5  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions

Date modified: 2026-09-08T01:19:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.